1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt Ruchika Sharma11 Dec 2022 4:00 PM ISTNew Delhi: A total of 1.5 lakh Covid vaccine doses have been procured by the government from Zydus Cadila at Rs 375.90 per jab (including GST),...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Zydus gets USFDA nod for diabetes drug Dapagliflozin MD Bureau24 Feb 2022 12:08 PM ISTAhemdabad: Zydus has recently announced that the company has received final approval from the US Food and Drug Administration (USFDA) to market...
Zydus Pharma gets USFDA nod for Roflumilast Tablets Ruchika Sharma14 Feb 2022 11:16 AM ISTAhmedabad: Zydus' U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received final approval from the US Food and Drug Administration (USFDA) to...
Zydus Cadila starts supply of COVID-19 vaccine to govt Ruchika Sharma2 Feb 2022 2:30 PM ISTNew Delhi: Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. The company...
Zydus Cadila Announces COVID-19 Vaccine Expansion Plan to Multiple Countries With Korean Firm Medical Dialogues Bureau6 Jan 2022 11:52 AM ISTGOLDEN: PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with...
Zydus Pharma bags USFDA nod for Pimavanserin Capsules Ruchika Sharma1 Jan 2022 11:15 AM ISTAhmedabad: Zydus Cadila's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the US Food and Drug Administration...
Zydus gets USFDA nod to Pimavanserin for Parkinson's disease-linked psychosis Ruchika Sharma23 Dec 2021 11:55 AM ISTAhmedabad: Drugmaker, Zydus Cadila has received tentative approval from the US Food and drug Administration (USFDA) to market Pimavanserin Tablets,...
Zydus Cadila novel compound to treat malaria ZY-19489 gets Orphan Drug Designation from USFDA Ruchika Sharma16 Dec 2021 3:25 PM ISTAhmedabad: Zydus Cadila, a research-driven, global healthcare provider, today announced that its antimalarial compound ZY19489 (MMV253),...
Zydus Cadila gets USFDA nod for Schizophrenia drug Cariprazine Ruchika Sharma11 Dec 2021 3:29 PM ISTAhmedabad: Pharma major, Zydus Cadila, has recently announced that the company's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received...
Zydus initiates phase 2b, 3 adaptive pivotal clinical trial of Saroglitazar Mg Ruchika Sharma10 Dec 2021 4:33 PM ISTAhmedabad: Zydus, a discovery based, global pharmaceutical company today announced that it has received permission from the United States Food and...
Centre to roll out Zydus Cadila COVID vaccine ZyCoV-D among 7 states Ruchika Sharma3 Dec 2021 2:54 PM ISTNew Delhi: Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West...
